"The FGF5 inhibitor aptamers add to the Company’s proprietary antiaging hair care technologies and underpin Cellmid’s scientific leadership in the field". (My emphasis)
Yeah well, far be it for me to be negative...but I've seen this type of exciting statement before (specifically...midkine) and in the end that got all too hard for them to materialise into something monetarily tangible.
As per Bariscan, I wonder if this ends up the same - or whether they can actually convert this into a money spinner "for the poor suffering shareholders"!
Only time will tell.
Ann: Cellmid Publishes Data on Novel Proprietary FGF5 Aptamer, page-4
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1285002 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 340000 | 1 |
View Market Depth
| Last trade - 16.12pm 01/07/2024 (20 minute delay) ? |
| AN1 (ASX) Chart |
Day chart unavailable